1. Electronic Bypass for Diabetes: Optimization of Stimulation Parameters and Mechanisms of Glucagon-Like Peptide-1
- Author
-
Jiande D. Z. Chen, Jieyun Yin, Yan Dong, and Yiling Zhang
- Subjects
Blood Glucose ,medicine.medical_specialty ,Incretin ,Stimulation ,Gastric Inhibitory Polypeptide ,Diabetes Mellitus, Experimental ,03 medical and health sciences ,0302 clinical medicine ,Glucagon-Like Peptide 1 ,Internal medicine ,Diabetes mellitus ,medicine ,Pulse frequency ,Animals ,business.industry ,digestive, oral, and skin physiology ,Antagonist ,Type 2 Diabetes Mellitus ,General Medicine ,Glucose Tolerance Test ,medicine.disease ,Glucagon-like peptide-1 ,Peptide Fragments ,Rats ,Anesthesiology and Pain Medicine ,Endocrinology ,Neurology ,Hyperglycemia ,Neurology (clinical) ,Electronics ,business ,hormones, hormone substitutes, and hormone antagonists ,030217 neurology & neurosurgery ,Hormone - Abstract
Intestinal electrical stimulation (IES) has been proposed for treating diabetes; however, its parameters need to be further systematically optimized. This study aimed to optimize the parameters of IES and investigate its possible mechanisms involving glucagon-like peptide-1 (GLP-1) in diabetic rats.Thirty-six high-fat diet-induced diabetic rats were chronically implanted with a pair of bipolar electrodes at the duodenum for IES. The oral glucose tolerance test (OGTT) was performed in a number of sessions with IES using different parameters and biphasic charge-balanced waveforms to derive the best values for train on-time, pulse frequency, and pulse width. Incretin hormones such as GLP-1 were assessed and the GLP-1 antagonist Exendin 9-39 was used to assess the role of GLP-1 in the ameliorating effect of IES on hyperglycemia.The most effective IES parameters in reducing blood glucose (BG) during the OGTT were derived: 1.2 sec on, 0.3 sec off, 80 Hz, 3 msec. IES with these parameters reduced BG level by at least 29% from 15 min to 180 min (p 0.05 for all points, N = 10). IES with these stimulation parameters increased plasma GLP-1 level at 30 min, 60 min, 90 min and gastric inhibitory peptide (GIP) level at 30 min (N = 8). Exendin 9-39 blocked the inhibitory effect of IES on BG (p 0.05, IES + Exendin 9-39 vs sham-IES, N = 8).IES with the most effective parameters derived in this study improves hyperglycemia in diabetic rats. The ameliorating effect of IES on hyperglycemia is attributed to the enhanced release of GLP-1. IES has great potential for treating diabetes.
- Published
- 2022